Efficacy observation of percutaneous vertebroplasty combined with zoledronic acid in treatment of spinal metastatic carcinoma

Abstract

Objective To observe the efficacy of percutaneous vertebroplasty (PVP) combined with zoledronic acid in treatment of spinal metastatic carcinoma. Methods Fifty cases of spinal metastatic carcinoma were divided into control group and treatment group by random digits table method with 25 cases each. The control group was given zoledronic acid 4 mg, intervals of 28 d intravenous drip 1 time. The treatment group was given PVP besides zoledronic acid. The visual analog scale score, activity ability score and analgesic usage score after treatment for 3 months were observed and compared. The quality of life was evaluated and the occurrence of relapse of fracture was also recorded. Results After treatment for 3 months, the visual analog scale score, activity ability score and analgesic usage score were (2.00±0.17), (2.12±1.38), (1.47±0.10) scores in treatment group, and (7.84±0.18), (3.21±0.13), (3.30±0.09) scores in control group, and there were significant differences between two groups (P < 0.01 or < 0.05). The occurrence of relapse of fracture was 2 cases (8%, 2/25) in treatment group and 9 cases (36%, 9/25) in control group, and there was significant difference between two groups (P < 0.05). Conclusions PVP combined with zoledronic acid in treatment of spinal metastatic carcinoma has many advantages such as small incision, short surgery time and rapid relief from pain. It can obviously improve the quality of life, and it is worthy of spreading in the clinic. Key words: Vertebroplasty; Spinal diseases; Neoplasm metastasis; Zoledronic acid